Showing results (1-10 of 525) with videos related to
Sort By:
Pageof 53
The International Journal of Neuropsychopharmacology|June 23, 2020
Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic TreatmentMarkus Dold, Lucie Bartova, Siegfried KasperPsychotherapy and Psychosomatics|September 14, 2017
Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled TrialsMarkus Dold, Lucie Bartova, Rainer Rupprecht, et al.Journal of Psychiatric Research|February 10, 2019
Seasonality of antidepressant prescriptions and sick leavesDietmar Winkler, Berthold Reichardt, Georg S Kranz, et al.Frontiers in Psychiatry|March 11, 2021
Case Report: Bupropion Reduces the [<sup>123</sup>I]FP-CIT Binding to Striatal Dopamine TransporterIvan Milenkovic, Lucie Bartova, Konstantinos Papageorgiou, et al.European Archives of Psychiatry and Clinical Neuroscience|March 9, 2022
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisitedLucie Bartova, Markus Dold, Hans-Peter Volz, et al.European Archives of Psychiatry and Clinical Neuroscience|January 30, 2023
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trialsMarkus Dold, Lucie Bartova, Hans-Peter Volz, et al.Journal of Affective Disorders|June 22, 2016
Bipolar II disorder as a risk factor for postpartum depressionLaura Mandelli, Daniel Souery, Lucie Bartova, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 26, 2018
Rapid antidepressant effect of S-ketamine in schizophreniaLucie Bartova, Konstantinos Papageorgiou, Ivan Milenkovic, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|March 1, 2024
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trialsMarkus Dold, Hans-Jürgen Möller, Hans-Peter Volz, et al.Pageof 53